KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) EBITDA Margin (2016 - 2026)

Amgen has reported EBITDA Margin over the past 18 years, most recently at 30.94% for Q1 2026.

  • For Q1 2026, EBITDA Margin rose 1648.0% year-over-year to 30.94%; the TTM value through Mar 2026 reached 28.39%, up 658.0%, while the annual FY2025 figure was 24.71%, 299.0% up from the prior year.
  • EBITDA Margin for Q1 2026 was 30.94% at Amgen, up from 27.57% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 485.84% in Q4 2022 and troughed at 13.31% in Q1 2024.
  • A 5-year average of 54.56% and a median of 28.94% in 2025 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: surged 45218bps in 2022 and later tumbled -47033bps in 2023.
  • Year by year, EBITDA Margin stood at 485.84% in 2022, then crashed by -97bps to 15.51% in 2023, then skyrocketed by 64bps to 25.43% in 2024, then rose by 8bps to 27.57% in 2025, then increased by 12bps to 30.94% in 2026.
  • Business Quant data shows EBITDA Margin for AMGN at 30.94% in Q1 2026, 27.57% in Q4 2025, and 26.43% in Q3 2025.